Target intelligence / Profile preview

TATA-box binding protein associated factor 9b pseudogene 1 (TAF9BP1)

Target: TAF9BP1
Molecular classification: Pseudogene

Overview

TATA-box binding protein associated factor 9b pseudogene 1 (TAF9BP1) is a human non-coding pseudogene that shares sequence similarity with the TATA-box binding protein associated factor 9B (TAF9B) gene, but does not produce a functional protein[2][4][9]. Pseudogenes such as TAF9BP1 arise by duplication or mutation of protein-coding genes and are characterized by loss of coding potential due to disabling mutations[6][9]. There is no evidence supporting TAF9BP1 involvement in cell signaling, transcription regulation, or in any disease processes. It should not be confused with TAF9B, a protein-coding gene that plays a vital role in the regulation of gene expression via RNA polymerase II[3][7].

Other names: TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa pseudogene 1Species: Human TAF9BP1 (246135)

Mechanism of action

Not applicable (no known drug interactions)

Biological functions

None directly; pseudogenes generally do not encode functional proteins. In rare cases, pseudogenes can influence gene regulation by acting as competing endogenous RNAs or through antisense interactions, but no such function is described for TAF9BP1

Disease associations

None reported for TAF9BP1. Some pseudogenes modulate disease pathways (e.g., cancer) in specific cases, but TAF9BP1 is not established in any disease context

Safety considerations

None (not a therapeutic target nor an expressed gene product)

Interacting drugs

None

Biomarkers

None described

Beyond the preview

Go deeper on TATA-box binding protein associated factor 9b pseudogene 1 (TAF9BP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor 9b pseudogene 1 (TAF9BP1).

Explore the full profile